VARUN M

“Silicon isn’t just for computers. It can make a pretty good kidney, too” @WIRED #NephMadness 💪 contender in the #ArtificialKidney region 💥The device incorporated with silicon nanotechnology & tissue engineering - Let’s talk about The Implantable Bioartificial Kidney #NSMC

Team @SalfordRenal @ #UKKW26

I have been drafting my dream AI-powered nephrology outpatient clinical workflow 🩺📈 and would love to share my thoughts 😊🤔 Discussion more on @ASNKidney AI forum community.asn-online.org/discussion/ai-… As shown in the table, AI tools support each phase of the outpatient nephrology workflow: Pre-visit, AI synthesizes EHR data 📋🤖 to highlight recent hospitalizations, medication changes, and abnormal labs. Risk models 🚩 prioritize high-acuity patients, while NLP triage identifies urgent referral reasons—ensuring a focused visit. During the visit 🧑‍⚕️👩‍⚕️, ambient scribes and NLP tools 📝 reduce clerical burden, enhancing patient interaction. Decision-support systems integrate real-time data to guide evidence-based care 💊🧬, flag care gaps, and suggest personalized plans 📚✅. Post-visit, AI monitors results and messages 📲🔁, triggering alerts for clinical deterioration. Home monitoring and AI inbox triage improve follow-up, reduce delays, and minimize unnecessary visits 🌐❤️‍🩹. @MayoClinicNeph

1/10 Last #NephJC we discussed the combination therapy of empagliflozin and finerenone 💊 #TenPostNephJC 🌵From a therapeutic dessert to a flood of options in DKD - what is the best timing to keep the kidneys afloat

Delighted to see our work from our advanced kidney care service published @IbrahimZeal1990 @rdonne10 @NCAresearchNHS

DAPA-Tolvaptan: First trial of SGLT2 inhibition in ADPKD with background tolvaptan therapy @KIReports made it to the #TOM in this #ISNGTF May issue. See the latest #ISNGTF summary for details. VA by @md_abdulqader83

GLP-1-based therapeutics for cardiorenal protection in metabolic diseases 🆓doi.org/10.1093/ndt/gf…

Delighted to see so many of our @salfordrenal colleagues speaking at #UKKW2025 inc @SmeetaSinha @hurstnellibert @tinachrysochou Tom McDonnell, Phil Kalra, Darren Green, Saif Al-Chalabi

Team @SalfordRenal at #UKKW25

🧵1/10 📢 New Definition in Nephrology Disease-Modifying Anti-Nephropathic Drugs (DMANDs) – A definition proposed by Immunonephrology Working Group (IWG) of the European Renal Association (ERA). Why does this matter? Let’s break it down! 🔗 doi.org/10.1093/ndt/gf… @NDTsocial An @ERAkidney e-seminar by @ykoteng_LUMC moderators @willkidney and Dr Parminder Judge, panelist @AKronbichler

First in Novel CKD Treatments Beyond the Pillars (room K), Jonathan Barratt presenting 🥁Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart Zigakibart= humanized MAb that blocks APRIL, a soluble factor whose blood level is elevated in patients with IgAN. #era25 6/

💥 Game Changers in CKD and T2DM 💥 first up Peter Rossing on GLP1s ▶️Early CV studies suggested kidney benefits of GLP1s ▶️Flow trial designed to look at kidney outcomes in DKD 💥 Showed improvement in composite kidney outcomes, eGFR slope, cardiovascular outcomes and all cause mortality. 💥💥 NNT only 20 for composite kidney outcomes when treated for 3 years 💥 Outcomes similar if already on SGLT2 (15%)or on MRA ( 7%) -▶️ benefits additive! 💥More to come- tirzepatide also showing big effects and more trials on the way 💥💥Exciting times! 💥💥 - Sarah Gleeson

#ERA25 #BeyondNephrology 1/And now one of the most awaited sessions in Late Breaking Clinical Trials 1: Cutting-Edge Clinical Trials in #Nephrology🥁 🚨 THE CONFIDENCE TRIAL: EFFICACY/SAFETY OF COMBINING FINERENONE WITH EMPAGLIFLOZIN IN PEOPLE WITH CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES 👤Rajiv Agarwal ✖️@AgarwalRajivMD 👤 Peter Rossing ✖️@P_Rossing 👤 Hiddo J.L. Heerspink ✖️@HeerspinkHiddo 👤 Johannes F.E. Mann

Presented at #ERA25: In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk @ERAkidney

🔴Approach to Resistant Hypertension⤵️ #2024Review #OpenAccess 🔹link.springer.com/article/10.100… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

@AINUKidneyRun "Optimising prescription practises" This #WorldKidneyDay AINU team promotes best prescription practises for optimal outcomes.. Creating awareness by annual running event..

4th edition of @AINUKidneyRun held on the eve of @worldkidneyday was a huge success with over 1500 runners showing their support to spread awareness in kidney health ! @KomatireddyKVR garu flagged off the run 🏃‍♀️🙏🏻 @360lifeEL @MercedesBenzInd Mahavir motors Thank you 🙏🏻

✨ Embracing luminous traditions, the #TransplantConclave 🌟 begins with a vibrant inauguration. Dr MV Rao sir gave inspiring opening remarks. Program director @srikanthnephro addressed the distinguished audience @ainuindia @ainunephrology

AINU Transplant Conclave in association with @HydNephForum ! Join us to see the experts comment and deliberate on various topics on 13th and 14th May @Hyatt Place, Hyderabad @AinuNephrology @isn_india @ISNkidneycare @srikanthnephro @DrPSVali @dakidneydoc @varunnephro @navinath_m

Thanks for the overwhelming response to the #AINUKidneyrun Honoured to have the stalwarts in Nephrology participating🙏🙏🙏 @SwarnalathaGud2 @drmanishasahay @DrPSVali #WorldKidneyDay @srikanthnephro @varunnephro @sujeethbande @kranthi_nephro

Hey #Nephpearls followers #NephMadness 2️⃣🏀2️⃣3️⃣ is upon us‼️ LIKE ❤️ If this is the first time you’ve heard about it (if so, please click on link) RETWEET 🔄 If you’re going to participate Link 👉🏼 ajkdblog.org/2022/03/01/wel… via @AJKDonline